CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Post-Acute COVID-19 Syndrome

Post acute stage of COVID-19 virus infection including signs, symptoms, and conditions that continue or develop after acute COVID-19 infection. Persistent symptoms may include FATIGUE; DYSPNEA; and MEMORY LOSS.

Drugs by status

Phase 4 trials (2)

  • ivabradine
  • thiamine

Phase 3 trials (11)

  • ritonavir
  • ibudilast
  • mepolizumab
  • pine bark extract
  • pentoxifylline
  • cellulose
  • allogeneic cord blood
  • trigonella foenum-graecum
  • oxygen
  • anakinra
  • nirmatrelvir

Phase 2 trials (10)

  • cyclobenzaprine
  • naltrexone
  • immune globulin (human)
  • rintatolimod
  • pyridostigmine bromide
  • blood plasma
  • sodium chloride
  • plitidepsin
  • s-217622
  • aer002

Phase 1 trials (4)

  • liraglutide
  • amantadine
  • bupivacaine
  • [11c]cppc

Other trials (6)

  • 18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose
  • vitamin d3
  • mitoquinone
  • flavonoids
  • 4-aminopyridine
  • covidex

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.